Related Experiment Video
Updated: May 27, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Tetracyclines: drugs with huge therapeutic potential
F Bahrami1, D L Morris, M H Pourgholami
1University of New South Wales Department of Surgery, St George Hospital, Sydney, Australia. mh.pourgholami@unsw.edu.au
Mini Reviews in Medicinal Chemistry
|November 11, 2011
Summary
Doxycycline and minocycline, modified tetracyclines, show significant anti-inflammatory and neuroprotective effects. Ongoing clinical trials are exploring their expanded therapeutic potential in diverse diseases.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Immunology
Background:
- Tetracyclines are a class of chemical agents with established therapeutic uses.
- Structural modifications yielded doxycycline and minocycline with improved pharmacokinetic properties and potency.
- These agents exhibit diverse pharmacological properties, including anti-inflammatory, immune-modulating, and neuroprotective effects.
Purpose of the Study:
- To review the chemistry and pharmacology of tetracyclines, focusing on doxycycline and minocycline.
- To discuss the mechanisms underlying their therapeutic effects, particularly matrix metalloproteinase and pro-inflammatory cytokine inhibition.
- To highlight the expanding therapeutic applications and potential of tetracyclines.
Main Methods:
- Literature review of pre-clinical and clinical studies on tetracyclines.
- Analysis of chemical structures and pharmacokinetic profiles of doxycycline and minocycline.
- Examination of data from over 200 ongoing clinical trials.
Main Results:
- Doxycycline and minocycline possess enhanced lipophilicity, oral bioavailability, and potency compared to natural tetracyclines.
- These compounds demonstrate significant anti-inflammatory, immune-modulating, and neuroprotective activities.
- Clinical trials are investigating tetracyclines for dermatological, neurological, immunological, cardiovascular, and oncological conditions.
Conclusions:
- Tetracyclines, particularly doxycycline and minocycline, have a broad therapeutic potential beyond their traditional uses.
- Their ability to inhibit matrix metalloproteinases and pro-inflammatory cytokines is key to their renewed therapeutic interest.
- Further research and clinical trials are expected to redefine and expand the applications of tetracyclines in medicine.
More Related Videos
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.